Sundar PichaiSundar Pichai earned $164M in 2023

Mark C. Throdahl is the Executive Chairman of OrthoPediatrics Corp., a company that specializes in orthopedic solutions for children. Throdahl has been steering the ship since he became CEO in 2011 and played a crucial role in its growth and...

Quick Links
O

Mark C. Throdahl

Ex-CEO of OrthoPediatrics

Education

MBA from Harvard Business School

Field of Expertise

Business & Management

Sector of Economy

Healthcare

Born

January 1, 1951 - 74 years ago

CEO of OrthoPediatrics for

10 years 5 months (Jan 2011 - Jun 2021)

Previous Experience

Group President of Zimmer Holdings, CEO of Consort Medical plc, Senior Vice President at Becton Dickinson & Co.

Rivals

Competitors/colleagues of Mark C. Throdahl

Holdings

See how much did Mark C. Throdahl make over time.

Mark C. Throdahl holds 162,787 shares of OrthoPediatrics common stock. His ownership peaked with 174,234 shares in early 2021 when he was transitioning to Executive Chairman. Over the years, his shareholding fluctuated, showing fluctuations tied to company performance and compensation...

Loading...

Total Stock Sold

$4.86M

KIDS

$4.86M

110,820 KIDS shares

What if they kept their stock?

If Mark C. Throdahl didn't sell their stock, today they would have:
Extra KIDS110,820 shares worth $4.72M.
This is -2.75% and $133.36K less than what they got when they sold the stock.

Charitable Transactions

KIDS

4,600 shares

KIDS

Recent Charitable Transactions

KIDS

600 shares

KIDS

Dec 31, 2022

Charity

KIDS

3,000 shares

KIDS

Dec 20, 2021

Charity

KIDS

1,000 shares

KIDS

Jun 13, 2019

Charity

Insider Trading

See recent insider trades of Mark C. Throdahl.

KIDS

21,623 shares

KIDS

Jun 11, 2024

Received

KIDS

$67.13K

KIDS at $27.59/share

Mar 11, 2024

Sale

KIDS

12,266 shares

KIDS

Mar 15, 2023

Received

KIDS

$197.87K

KIDS at $43.83/share

Mar 6, 2023

Sale

KIDS

600 shares

KIDS

Dec 31, 2022

Charity

KIDS

10,363 shares

KIDS

Mar 15, 2022

Received

KIDS

$349.31K

KIDS at $58.60/share

Mar 2, 2022

Sale

KIDS

3,000 shares

KIDS

Dec 20, 2021

Charity

KIDS

$312.22K

KIDS at $65.40/share

Aug 3, 2021

Sale

KIDS

$1.00M

KIDS at $65.88/share

Aug 2, 2021

Sale

Compensation History

See how much did Mark C. Throdahl make over time.

In 2021, Mark C. Throdahl was compensated with a total package of $718,032. His salary was $314,958, but the bulk came from a $400,000 bonus tied to company performance metrics like sales and adjusted EBITDA. His compensation reflects a successful performance strategy, achieving nearly 80% of set goals. Additionally, he received stock awards worth $315,881 that vested that year. The compensation strategy at OrthoPediatrics is designed to motivate top executives through performance-based bonuses, linking pay directly to the company's success, which Throdahl's tenure exemplifies through his notable financial achievements over his years at the helm.

Year

2021

Total Compensation

$1.15M

Salary

$314.96K

Board Justification

The compensation philosophy aligns with company performance and aims to attract, retain, and motivate executives while ensuring that the compensation is competitive within the industry.

Bonus

$400.00K

Board Justification

The bonus reflects achievement of performance criteria under the executive bonus plan for 2021, based on specified sales, adjusted EBITDA, and Company objectives, with actual bonuses paid reflecting achievement of 79.54% of the annual performance goals.

Other

$120.15K

Board Justification

Other compensation includes lodging and travel expenses incurred in connection with his travel between the company's headquarters and his primary residence, as well as 401(k) matching contributions.

Restricted Stock

$315.88K(5.28K restricted stock)

Board Justification

The stock awarded to Mr. Throdahl that vested in 2021 as part of the company's equity incentive plan, which typically vests over three years.

Performance Metrics

The performance metrics for determining Mr. Throdahl's compensation included specified sales targets, adjusted EBITDA, and overall company objectives.

Other OrthoPediatrics CEOs

Here are other CEOs of OrthoPediatrics